|
FUJIFILM VisualSonics Inc
mouse two-dimensional echocardiography platform ![]() Mouse Two Dimensional Echocardiography Platform, supplied by FUJIFILM VisualSonics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/echocardiography+platforms/mouse+two+dimensional+echocardiography+platform/pmc10069815-116-2-12 Average 90 stars, based on 1 article reviews
mouse two-dimensional echocardiography platform - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Vingmed AS
ge vivid s6 dimension echocardiography platform with a 10 mhz linear array transducer ![]() Ge Vivid S6 Dimension Echocardiography Platform With A 10 Mhz Linear Array Transducer, supplied by Vingmed AS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/echocardiography+platforms/ge+vivid+s6+dimension+echocardiography+platform+with+a+10+mhz+linear+array+transducer/pm36078158-42-16-20 Average 90 stars, based on 1 article reviews
ge vivid s6 dimension echocardiography platform with a 10 mhz linear array transducer - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
FUJIFILM VisualSonics Inc
echocardiography platform ![]() Echocardiography Platform, supplied by FUJIFILM VisualSonics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/echocardiography+platforms/echocardiography+platform/bio_rxiv__2025__06__04__657956-59-49-56 Average 90 stars, based on 1 article reviews
echocardiography platform - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
FUJIFILM VisualSonics Inc
mouse twodimensional echocardiography platform ![]() Mouse Twodimensional Echocardiography Platform, supplied by FUJIFILM VisualSonics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/echocardiography+platforms/mouse+twodimensional+echocardiography+platform/pm36545872-69-2-12 Average 90 stars, based on 1 article reviews
mouse twodimensional echocardiography platform - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
FUJIFILM
echocardiography platform ![]() Echocardiography Platform, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/echocardiography+platforms/echocardiography+platform/pmc05682408-65-2-15 Average 90 stars, based on 1 article reviews
echocardiography platform - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Physiological Research
Article Title: Hydrogen Sulfide Alleviates Lipopolysaccharide-Induced Myocardial Injury Through TLR4-NLRP3 Pathway
doi: 10.33549/physiolres.934928
Figure Lengend Snippet: Exogenous H2S amelio-rates myocardial tissue injury. (A) Representative M-mode images from Control, LPS, and LPS+NaHS groups. (B) Represen-tative HE-stained left ventricular sections (scale bar = 50 μm). (C) The changes of left ventri-cular ejection fraction (LVEF). (D) Pathological score of the HE-stained left ventricular sec-tions. (E) H2S levels in the SIMD mice model plasma. (F) cTnI levels in the SIMD mice model plasma. (G) TNF-α levels in the SIMD mice model plasma. (H) IL-1β levels in the SIMD mice model plasma. (I–J) Represen-tative Western blots and quan-tification of TLR4 and NLRP3 protein expression in heart tissues. β-actin was used as the internal control. n=8 in every mice model group. n=5 in every Western blot group. Results are means ± SEM. * P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001. P<0.05 was considered significant.
Article Snippet: To evaluate
Techniques: Control, Staining, Clinical Proteomics, Western Blot, Expressing
Journal: Physiological Research
Article Title: Hydrogen Sulfide Alleviates Lipopolysaccharide-Induced Myocardial Injury Through TLR4-NLRP3 Pathway
doi: 10.33549/physiolres.934928
Figure Lengend Snippet: NLRP3 inhibitor, MCC950, attenuates LPS-induced myocardial injury. (A) Representative M-mode images from LPS, LPS+MCC950 and LPS+NaHS+MCC950 groups (B) Representative HE-stained left ventricular sections (scale bar = 50 μm). (C) The changes of left ventricular ejection fraction (LVEF). (D) Pathological score of the HE-stained left ventricular sections. (E) cTnI levels in the SIMD mice model plasma. (F) TNF-α levels in the SIMD mice model plasma. (G) IL-1β levels in the SIMD mice model plasma. n=8 in each group. Results are means ± SEM. * P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001. P<0.05 was considered significant.
Article Snippet: To evaluate
Techniques: Staining, Clinical Proteomics
Journal: Physiological Research
Article Title: Hydrogen Sulfide Alleviates Lipopolysaccharide-Induced Myocardial Injury Through TLR4-NLRP3 Pathway
doi: 10.33549/physiolres.934928
Figure Lengend Snippet: NaHS exerts protective effects mainly through the TLR4-NLRP3 signaling axis (A) Representative M-mode images from WT, WT+LPS, TLR4−/−+LPS, TLR4−/−+LPS+NaHS groups (B) Representative HE-stained left ventricular sections (scale bar = 50 μm). (C) The changes of left ventricular ejection fraction (LVEF). (D) Pathological score of the HE-stained left ventricular sections. (E) cTnI levels in the SIMD mice model plasma. (F) TNF-α levels in the SIMD mice model plasma. (G) IL-1β levels in the SIMD mice model plasma. n=8 in each group. Results are means ± SEM. * P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001. P<0.05 was considered significant.
Article Snippet: To evaluate
Techniques: Staining, Clinical Proteomics
Journal: bioRxiv
Article Title: A Transient Increase in Cardiomyocyte Protein O-GlcNAcylation Enhances Susceptibility to Pressure Overload-Induced Cardiac Remodeling
doi: 10.1101/2025.06.04.657956
Figure Lengend Snippet: Schematic showing the experimental timeline and procedures for the dnOGAh ON/OFF-TAC paradigm used in this study—from induction of dnOGA transgene via DOX, switching the transgene “off” via removal of DOX, and TAC procedure, to subsequent echocardiography and tissue harvesting for downstream analyses.
Article Snippet: At the prespecified timepoints shown in the experimental schema ( ) after 8 weeks of TAC/Sham, transthoracic echocardiography was performed on all mice in the study, as previously described., In brief, the mice were anesthetized via 2% isoflurane induction chamber inhalation then placed in a supine position on a
Techniques:
Journal: bioRxiv
Article Title: A Transient Increase in Cardiomyocyte Protein O-GlcNAcylation Enhances Susceptibility to Pressure Overload-Induced Cardiac Remodeling
doi: 10.1101/2025.06.04.657956
Figure Lengend Snippet: A) Normalized ratio of wet-dry lung weight to TL for Con-TAC and ON/OFF-TAC mice compared to age-matched Sham controls (Con-Sham and ON/OFF-Sham) ( n ≥ 29). B) Normalized ratio of wet-dry lung weight to TL for Con-TAC and ON/OFF-TAC mice compared to age-matched Sham controls (Con-Sham and ON/OFF-Sham) split by sex. C-G) Cardiac function measures via echocardiography split by sex for: cardiac systolic function as measured by LV ejection fraction from M-mode LV traces ( C ), stroke volume from M-mode LV traces ( D ), left ventricular internal dimension at diastole (LVIDd) ( E ), cardiac wall thickening as measured by LV posterior wall thickness at diastole (LVPWd) ( F ), and inter-ventricular septum thickness at diastole (IVSd) ( G ). Statistical significance was based on two-way ANOVA followed by Tukey’s multiple comparisons test (* p < 0.05, ** p < 0.01, *** p < 0.005). All calculated and analysis data are mean ± S.E.M.
Article Snippet: At the prespecified timepoints shown in the experimental schema ( ) after 8 weeks of TAC/Sham, transthoracic echocardiography was performed on all mice in the study, as previously described., In brief, the mice were anesthetized via 2% isoflurane induction chamber inhalation then placed in a supine position on a
Techniques:
Journal: Echo Research and Practice
Article Title: Transthoracic echocardiography is adequate for intraprocedural guidance of transcatheter aortic valve implantation
doi: 10.1530/ERP-17-0050
Figure Lengend Snippet: Transthoracic echocardiography during transcatheter aortic valve implantation procedure – excellent image quality. (A) Transthoracic parasternal short-axis view demonstrating severe calcific aortic valve stenosis. (B) Parasternal long-axis transthoracic view demonstrating normal depth, expansion and appearance immediately after transcatheter aortic valve implantation. Leaflets can be seen to move normally in these views. (C and D) Immediate post-implantation short-axis parasternal view and apical 5-chamber view demonstrating mild paravalvular regurgitation. In the short-axis view, normal Doppler interference from the transcatheter stent is visualized and the paravalvular regurgitation is turbulent. (E and F) Using a 4-dimensional (4D) transthoracic echocardiography probe, real-time 4D images were acquired that demonstrated the normal appearance of transcatheter aortic valve implantation immediately after the procedure, an en-face view from the aorta (E), and an en-face view from the left ventricular outflow tract (F).
Article Snippet: As all
Techniques:
Journal: Echo Research and Practice
Article Title: Transthoracic echocardiography is adequate for intraprocedural guidance of transcatheter aortic valve implantation
doi: 10.1530/ERP-17-0050
Figure Lengend Snippet: Stacked bar graph of imaging characteristics of procedural echocardiography ( n = 278).
Article Snippet: As all
Techniques: Imaging
Journal: Echo Research and Practice
Article Title: Transthoracic echocardiography is adequate for intraprocedural guidance of transcatheter aortic valve implantation
doi: 10.1530/ERP-17-0050
Figure Lengend Snippet: Transthoracic echocardiography visualized intraprocedural pericardial effusion and tamponade – fair image quality. (A) Transthoracic parasternal long-axis view demonstrating severe calcific aortic stenosis and no pericardial effusion. (B) Immediately after transcatheter aortic valve implantation, pericardial effusion was visualized (orange arrow). (C) This pericardial effusion was redemonstrated on parasternal short-axis view and appeared larger; the left ventricle was demonstrated to be underfilled. This combined with hypotension required emergency endotracheal intubation and sternotomy. A pericardiocentesis was performed and a wire perforation was identified in the left ventricle and repaired. Despite fair image quality, trace paravalvular regurgitation was identified on TTE. (D and E) This same jet of paravalvular regurgitation was also noted on TOE images in short-axis and long-axis (F) esophageal views (green arrows).
Article Snippet: As all
Techniques:
Journal: Echo Research and Practice
Article Title: Transthoracic echocardiography is adequate for intraprocedural guidance of transcatheter aortic valve implantation
doi: 10.1530/ERP-17-0050
Figure Lengend Snippet: Assessment of paravalvular regurgitation in transthoracic TAVI ( n = 278 patients) at procedural echocardiography, 24-h echocardiography ( n = 278) and 1-month echocardiography ( n = 236). Echo = echocardiography; TAVI = transcatheter aortic valve implantation.
Article Snippet: As all
Techniques: